Home373110 • KOSDAQ
add
Xcell Therapeutics Inc
Previous close
₩4,500.00
Day range
₩4,505.00 - ₩4,860.00
Year range
₩3,385.00 - ₩12,900.00
Market cap
50.55B KRW
Avg Volume
600.30K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 457.81M | 53.99% |
Operating expense | 2.41B | 57.07% |
Net income | -2.69B | -40.75% |
Net profit margin | -587.02 | 8.60% |
Earnings per share | — | — |
EBITDA | -2.30B | -54.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.94B | — |
Total assets | 19.25B | — |
Total liabilities | 7.93B | — |
Total equity | 11.32B | — |
Shares outstanding | 10.92M | — |
Price to book | 4.34 | — |
Return on assets | -50.72% | — |
Return on capital | -60.91% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -2.69B | -40.75% |
Cash from operations | -2.54B | -70.79% |
Cash from investing | -379.60M | -2,068.71% |
Cash from financing | 14.78B | 9,783.87% |
Net change in cash | 11.86B | 832.07% |
Free cash flow | -1.90B | — |
About
Founded
2015
Website
Employees
61
